BRIEF-Eiger reports additional positive phase 2 results from multiple-ascending dose study of exendin 9-39
June 12, 2017 at 08:18 AM EDT
* Eiger reports additional positive phase 2 results from multiple-ascending dose study of exendin 9-39 in post-bariatric hypoglycemia patients at american diabetes association meeting in san diego
